Feb 23, 2023 03:49AM
Dec 27, 2022 04:30PM
Dec 27, 2022 04:30PM
Dec 27, 2022 04:30PM
Nov 10, 2022 04:45PM
Nov 10, 2022 07:07AM
Nov 10, 2022 07:00AM Jounce Therapeutics Reports Third Quarter 2022 Financial Results
Oct 27, 2022 08:00AM
Aug 4, 2022 07:00AM
Jul 28, 2022 08:00AM
May 6, 2022 05:24AM
May 5, 2022 07:00AM
Apr 28, 2022 08:00AM
Mar 2, 2022 07:00AM Jounce Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 23, 2022 08:00AM
Nov 10, 2021 05:05PM
Nov 4, 2021 03:47PM
Nov 4, 2021 07:00AM
Oct 28, 2021 08:00AM
Aug 5, 2021 07:00AM
Jul 29, 2021 08:00AM Jounce Therapeutics to Announce Second Quarter 2021 Financial Results and Host a Conference Call on Thursday, August 5, 2021
May 4, 2021 06:30AM
Apr 27, 2021 08:00AM
Feb 25, 2021 06:30AM
Feb 18, 2021 08:00AM
Nov 6, 2020 07:00AM
Oct 30, 2020 08:00AM
Aug 7, 2020 06:30AM Jounce Therapeutics Reports Second Quarter 2020 Financial Results
Jul 31, 2020 08:00AM
May 6, 2020 06:30AM
Apr 29, 2020 08:00AM
Feb 27, 2020 06:30AM
Feb 21, 2020 01:25PM
Nov 7, 2019 06:30AM
Oct 31, 2019 08:00AM Jounce Therapeutics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Thursday, November 7, 2019
Aug 7, 2019 06:30AM
Jul 31, 2019 08:00AM
Jul 24, 2019 09:26AM
Jul 23, 2019 05:40PM
May 8, 2019 06:30AM
May 1, 2019 08:00AM
Mar 6, 2019 06:34AM Jounce Therapeutics (JNCE) Tops Q4 EPS by 30c, Revenues Beat; Offers FY19 Revenue Outlook Below Consensus
Mar 6, 2019 06:30AM
Feb 28, 2019 08:00AM
Nov 28, 2018 09:00AM
Nov 13, 2018 06:30AM
Nov 6, 2018 08:00AM
Oct 19, 2018 09:15AM
Aug 9, 2018 06:36AM Jounce Therapeutics (JNCE) Reports Q2 Loss of $0.14/Share
Aug 9, 2018 06:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All